Dr. Usama Gergis, MD

Dr. Gergis practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Gergis' NPI, 1548450984, was assigned on August 1, 2007. Dr. Gergis holds Pennsylvania license MD469443.

Dr. Gergis' primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000.

Dr. Gergis' primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Gergis is also affiliated with Lehigh Valley Hospital-Cedar Crest. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Gergis to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gergis practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gergis' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Gergis' licenses on file in 2 states: Pennsylvania and New York.

CMS data shows 287 Medicare services from Dr. Gergis across 2 procedure codes in 2024, for 54 Medicare patients. Medicare paid $27,617 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 54 Medicare patients who saw Dr. Gergis in 2024. The largest group is 65 to 74, with 43 patients. 67% of them have high blood pressure, and 67% have high cholesterol. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gergis' median patient age at 61, with 42% women.

In 2019, Dr. Gergis wrote 76 Medicare Part D claims. They cover 4 drugs, with $50,850 in total drug cost. In 2018, CMS named 38 claims across 2 drugs.

Dr. Gergis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 86 papers to Dr. Gergis, published from 2017 to 2025. 2020 was the busiest year, with 18. The most frequent topics are Hematopoietic Stem Cell Transplantation, Hematologic Neoplasms and Immunotherapy, Adoptive. Dr. Gergis has published most often in Bone Marrow Transplant. Dr. Gergis' most frequent co-authors are Jean A. Yared, MD, Shahrukh K. Hashmi, MD and Amer M. Beitinjaneh, MD.

CMS Open Payments shows 1,502 general payments to Dr. Gergis from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Incyte Corporation paid the most, $668,431. It also lists 1 research payment totaling $417 in 2017.